TAFAZZIN and cardiomyopathy: Exome sequencing identified a pathogenic variant in Tafazzin (TAZ c.212C > T), consistent with a diagnosis of Barth syndrome (diagnosis based on entry in a previous study at 3 weeks of age that included rapid genome sequencing) and related cardiomyopathy.